Showing results 2 to 2 of 2
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II Proceeding/Conference:Journal of Clinical Oncology | 2012 |